# Tigermed-Jyton acquires NAMSA China

Tigermed-Jyton, a medical device CRO in China, has acquired NAMSA China, the Chinese branch of global MedTech CRO NAMSA, and entered into an exclusive China regional partnership and global collaboration with NAMSA.

- Type: Acquisition
- Announced: 2024-02-29
- Where: Beijing, China, China
- Status: completed
- Products: medical device CRO services
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [NAMSA](https://endata.com/companies/49644.md) (partner)
- [Tigermed-Jyton](https://endata.com/companies/75930.md) (acquirer)
- [NAMSA China](https://endata.com/companies/75931.md) (target)

## Sources

- [tigermedgrp.com](https://www.tigermedgrp.com/en/media-resources/press-releases/152), 2024-02-28: "Tigermed-Jyton is excited to have NAMSA China joining our team."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.